Answer
Xydalba (dalbavancin) is contraindicated in anyone with hypersensitivity to dalbavancin or any of its excipients listed in section 6.1.
Sources for this answer
- Xydalba 500 mg powder for concentrate for solution for infusionADVANZ Pharma · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked